We’re excited to announce our speaker line-up for Hacking Health 2013. Our distinguished speakers will be helping us kick off the event on Friday 18th October and we’ve chosen a variety of topics that I hope you will find both useful and inspirational for the task ahead!
5:30-5:45pm: Harry Sacks (Novartis) – Creating a culture of innovation
5:45-6:00pm: Lisa Suennen (Psilos) – How to make a successful pitch
6:00-6:20pm: Jeff Tangney (Doximity) – Founding with friends
6:30-6:35pm: Horst Merkle (Genentech) – Changes in the mHealth regulatory landscape
Biographies of our speakers are below:
Harry Sacks, MD
VP and Medical Unit Head, Primary Care and EM
Novartis Pharmaceuticals Corporation
Harry Sacks, MD is Vice President of US Medical Affairs for Primary Care & Established Medicines at Novartis, a leading global pharmaceutical company based in Basel, Switzerland. In this role, he is responsible for assuring that customers receive timely and compliant scientific information on Novartis’ products. He has widespread leadership experience and success in medical affairs and clinical development of new drugs across multiple therapeutic areas – particularly for patients with respiratory diseases. Prior to joining Novartis, Harry held several positions of increasing responsibility at several pharmaceutical companies. He led the Respiratory Clinical Development Team at Forest Research Institute, a division of Forest Laboratories, Inc. Harry also served as Chief Medical Officer (CMO) for the US division of Meda (formerly MedPointe) Pharmaceuticals. MedPointe was a small start-up specialty pharmaceutical company that was the product of a LBO of the pharmaceutical division of Carter Wallace Pharmaceuticals. As a start-up, MedPointe had a strong entrepreneurial spirit, and a “roll up your sleeves” philosophy which intrigued Harry after spending 7 years at Schering-Plough Corp (now Merck), a large biopharmaceutical company. Each of these experiences in the pharmaceutical industry have provided him with a highly diverse background.
Harry earned his MD degree with Special Distinction in Research from Albert Einstein College of Medicine in NY, and completed residency training in Pediatrics followed by additional training in Anesthesiology at Thomas Jefferson University in Philadelphia. He served as Assistant Professor of Pediatrics at Jefferson Medical College and practiced acute and critical care pediatrics prior to joining industry.
Co-founder & Managing Member
Lisa Suennen is a co-founder and Managing Member of Psilos Group, a healthcare-focused investment firm with approximately $600 million under management that focuses on the medical device, healthcare information technology and healthcare services sectors. Psilos Group has backed some of the healthcare industry’s most important new healthcare ideas through companies such as ActiveHealth, Definity Health, Extend Health, InSound Medical, Mauna Kea Technologies, and SeeChange Health, Lisa currently serves as a Director on the Board of several Psilos portfolio companies, including AngioScore, PatientSafe Solutions, OmniGuide and VeraLight.
Prior to Psilos, Lisa was at Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and product management in companies in the high technology field.
Lisa has served as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program. She is also a member of the Qualcomm Life Advisory Board, a member of the Dignity Health Foundation Board, and a member of the Board of health IT company Beyond Lucid Technologies. Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley. Lisa has returned to UC Berkeley as Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University and as visiting lecturer at the U.C. Berkeley Haas School of Business where she teaches the annual course on healthcare venture capital. Lisa also writes a widely read blog on healthcare and healthcare investing at www.venturevalkyrie.com.
Jeff Tangney is the founder and CEO of Doximity, the largest real-name and physician-only network. Launched in November 2010, Doximity allows physicians to send HIPAA-compliant messages, fax directly from phone or web, search nationwide databases health care facilities and find contact information for over 500,000 physicians. Doximity aims to prevent medical miscommunication by simplifying day-to-day physician communication.
From 1998 to 2009, Jeff was the Co-Founder, President, and COO at Epocrates (Nasdaq: EPOC), the most popular physician software product of all time. Epocrates is actively used by over 45% of all US physicians today. Jeff built and managed a team of over 250 people, spanning all commercial, technical, and strategic functions. He led the efforts to raise $46 million in three rounds of venture capital, $40 million in a secondary from Goldman Sachs, and file an S-1.
In 2007, Jeff was voted the E&Y Entrepreneur of the Year for Northern California. The following year Jeff was named to the PharmaVoice100, a list of the 100 most influential people in life sciences.
Jeff and his wife Claudia have two children and live in San Mateo. Previously, they lived as Resident Fellows at Stanford. There they experienced the Facebook phenomenon firsthand in 2005, which became Jeff’s inspiration for Doximity. Jeff holds an M.B.A. from Stanford and a B.S. from the University of Wisconsin. He also admits he was twice the Wisconsin State high school math champion.
Director Information Management Systems Diabetes Care since 2003. In this position he is responsible for the innovative initiation, definition and the development of key components for the Roche Diabetes Management Solutions product portfolio with focus on decision support and mobile applications, interoperability/connectivity and standardization.
This position interfaces with all global and regional functions within the Roche Diabetes Care business.
A native German and with 30+ year experience in life sciences, health care and health informatics, he has spent most of his professional life in global marketing, business and product portfolio development positions. Horst has been living in the United States since 1997 interrupted by a 2 year assignment back at the Roche Diabetes Care Headquarters in Mannheim, Germany.
Before moving to the USA he worked 5 years as global marketing and portfolio manager for AVL Medical Instruments in Switzerland. Focus: Critical Care Blood Gas Analysis and Information Management.
With Roche’s strong engagement in the Continua Health Alliance Horst became member of the board of directors in June 2008 where he serves in the position of vice president and co-chair of the board. Between 2000 and 2003 Horst served on the executive committee of the Connectivity Industry Consortium (CIC). The CIC developed the accredited POCT-1 standard for Point-of-Care systems interoperability. From 2001 to 2004 he was a member of “Deutsches Institute für Normung” (German National Standards Organization) special interests group “Medical” called “NAMed”. Horst holds bachelors degrees in Organic Chemistry and Business Administration.